Involvement of Corticotropin-releasing Hormone-related Peptides in Cellular Stress Caused by Anticancer Drugs in Colorectal Cancer

Anticancer Res. 2020 Aug;40(8):4505-4511. doi: 10.21873/anticanres.14455.

Abstract

Background/aim: The expression of corticotropin-releasing hormone (CRH)-related peptides involved in stress response in colorectal cancer has been reported. We examined the involvement of CRH-related peptides in cellular stress caused by anticancer drugs in colorectal cancer.

Materials and methods: Changes in the expression levels of CRH-related peptides and their receptors in HCT116, DLD-1, and SW480 cell lines after fluorouracil (5-FU) loading were evaluated. Effects of the receptor antagonist against DNA synthesis disorder caused by 5-FU and SN-38 were evaluated using the 3H-labeled deoxyribonucleoside incorporation assay.

Results: No changes in the mRNA expression levels of CRH-related peptides (UCN and UCN2) -and their receptors (CRHR1 and CRHR2) were observed. Addition of antagonists to cells with DNA synthesis disorder caused by 5-FU and SN-38 showed no differences in the incorporation of 3H-labeled deoxyribonucleoside.

Conclusion: CRH-related peptides showed no effect on the stress response to anticancer drugs nor on DNA synthesis disorder in colorectal cancer.

Keywords: Colorectal cancer; anticancer drug; corticotropin-releasing hormone; stress.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / genetics*
  • Corticotropin-Releasing Hormone / genetics*
  • Fluorouracil / pharmacology
  • Gene Expression Regulation, Neoplastic / drug effects
  • HCT116 Cells
  • Humans
  • Irinotecan / pharmacology
  • Receptors, Corticotropin-Releasing Hormone / genetics*

Substances

  • Antineoplastic Agents
  • CRF receptor type 2
  • Receptors, Corticotropin-Releasing Hormone
  • CRF receptor type 1
  • Irinotecan
  • Corticotropin-Releasing Hormone
  • Fluorouracil